# Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes

> **NCT05717127** · NA · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 51 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Obesity

## Interventions

- **BEHAVIORAL:** Time restricted feeding
- **BEHAVIORAL:** Standard lifestyle

## Key facts

- **NCT ID:** NCT05717127
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05717127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05717127, "Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05717127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*